US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

10

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

176268667

Full Text :

https://doi.org/10.1200/JCO.23.02112